This is Product is very demand due to pandamic situation. We are supplying ICMR approved ,CE certified product
SARS-CoV-2 IgG/IgM Rapid Test Kit Intended Use: To detect IgM and IgG antibodies against N and S protein of SARS-CoV-2 in whole blood, serum and plasma Product Format: 25 tests/kit Kit Contents: test card, diluent, capillary, lancet, and instruction for use. Storage/Stability: 2 C to 30C for 12 months.� eproducibility /Precision 100% Concordant across 3 lots with CV ±5% Performance Comparison (A) China Validation Test Positive Samples 100 / 102 Sensitivity: 98.04% Negative Samples 491/492 Specificity: 99.80% Overall Accuracy: 99.49% Performance Comparison (B) Positive Samples 23 / 25 Sensitivity: 92% Negative Samples 25 / 25 Specificity: 100% Overall Accuracy: 96%
20 tests/box
covid antigen nasal rapid test passed the Germany PEI testing and registered on EU Common List
20 tests/box, 1 pcs/box, 5pcs/box
For in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasal (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days after onset of symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, not for at-home testing. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or 2019-nCoV) is an enveloped non-segmented positive-sense RNA virus. It is the cause of coronavirus disease (COVID-19), which is contagious in humans. SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M), and nucleocapsid (N). The antigen is generally detectable in upper respiratory samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out a bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, which do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. For in vitro diagnostic use only. For professional use only .
1. Nasopharynx swab specimen, non-invasive 2. Very simple to use 3. Convenient, no devices required 4. Rapid, results within 20 minutes 5. Cost-efficient 6:Listed on German BfArm ,got approval by PEI Clinical report from local CDC Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C). During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
Antigen Rapid Covid-19 Test Kit Medakit. Rapid diagnosis tests for Covid-19 infections (10 minutes). Cassette 40 test/kit. Main compound from Germany, assembly in China. Certifications : FDA - MOFCOM - CE - ANVISA - TGA - ISO13485 - ISP - CNR (Institut Pasteur)
Product Details: Usage/Application Hospital Time To Result 5-10 min SD BIOLINE Strep A rapid test is a chromatographic immunoassay for the qualitative detection of group A streptococcal antigens directly from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture. Detection of strep-A antigen directly from throat swab Easy to use: throat swab sample Optimal test for Group A streptococcal infection. Ordering Information Cat No. Description Specimen Pack Size 45FK12 Strep A Group A Throat swab 25 Tests Streptococcal Ag
Introducing our Rapid Malaria Testing Kit, a breakthrough in diagnosing malaria with speed and accuracy. This cutting-edge kit is designed for easy and quick detection of the malaria parasite, revolutionizing the way healthcare professionals identify this life-threatening disease. With a user-friendly approach, it requires only a small blood sample to deliver results within minutes, enabling swift and informed medical decisions. Our kit boasts high sensitivity and specificity, ensuring reliable diagnoses even in low-infection scenarios. Its compact design and portability make it ideal for remote and resource-limited settings. Trust our Rapid Malaria Testing Kit for fast, dependable, and life-saving malaria diagnosis, providing critical support in the fight against this global health challenge.
Our Rapid Typhoid Testing Kit is a cutting-edge solution for swift and accurate diagnosis of typhoid fever. This advanced kit is designed for quick detection of the Salmonella Typhi bacteria, streamlining the diagnostic process for healthcare professionals. With a user-friendly approach, it requires a small blood sample and delivers results within minutes, enabling rapid treatment decisions. The kit exhibits exceptional sensitivity and specificity, ensuring reliable diagnoses even in low-infection scenarios. Its compact, portable design makes it ideal for remote and resource-limited areas. Trust our Rapid Typhoid Testing Kit for fast, dependable, and life-saving typhoid fever diagnosis, enhancing patient care and containment of this infectious disease.
Antigen test kits Allocation Available 10 Million pcs/month MOQ : 2.5M Pcs $5.80 including (CIF Via AIR) SOP: ICPO/POF Commercial Invoice/SPA/POP SBLC AWB/SGS/Delivery SBLC Released
COVID-19 Antigen Rapid Test (Self-Test at Home) Immediate stock : 78,000 test kits OTG Price : USD13.80 per box (2 test kits per box)
Angiten-COVID-19 Virus Test Kit (Colloidal Gold) Quantity of box: 25 persons/box Brand: Easysweet NMPA (National Medical Products Administration): Approved CE: with CE mark BfArM: listed Test Method: Antigen Test Result Time: 10-15 mins Sample Type: Nasal Swab Sensitivity: 96.70% Specificity: 100% Accuracy: 98.94% Shelf Life: 24 months Storage Temperature: 2-30 Degree Celsius Country of Origin: Made in China Additional Information: Production Capacity: 1 million Delivery Time: 10-15 days Packaging Details: 25 tests in a pack, 40packs/ carton Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.
CTK biotech, OnSite Chikungunya IgM Combo Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM anti-chikungunya (CHIK) virus in human serum, plasma or whole blood. CE certified.
Product Details: Number of Reactions(Preps)/Kit : 30T Brand : CTK Biotech Result Time (Rapid Kits) ; 20mins Sample Type : Blood Test Type : Rapid Test CAT No : R0066C The OnSite Chikungunya IgM Combo Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM anti-chikungunya (CHIK) virus in human serum, plasma or whole blood.
Product Details: Brand : Abbott ICMR Approved ; Yes Sample Type : Nasal Swab Packaging Size : 25 Test Kits/Box Cat. No: 195000 The BinaxNOWTM COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset
1) Zhenrui (Immediate Stock) at HKD65 per test 2) Newgene (available in 3-5 days upon order) at HKD30 per test 3) Aripa (available on 22 Feb 2022) at HKD68 per test 4) Healgen (available in 1-2 weeks) at HKD48 per test 5) Giant King (available in 1-2 weeks) at HKD48 per test 6) BioTeke (immediate available - 1M) at HKD30 per test 7) TBG (MOQ : 1M) at USD4.50 per test
Antigen Detection Rapid Lateral Flow Test (latex bead-based) AIVD Biotech's Ag test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein (NP) antigen in direct nasal swabs from individuals suspected of infection. Description: This kit utilizes the principle of latex bead immunochromatography to qualitatively detect the Np antigen in human nasal swabs. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of suspected patients. The test contains latex bead conjugate pad and a membrane strip pre-coated with antibodies specific to the antigen on the test lines (T). If novel NP antigen is present in the specimen, a visible band appears on the test lines (T) as antibody-antigen-antibody latex bead complex forms. The control line (C) is used for procedural control and should always appear if the test is performed correctly. This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well. If sample contains the antigen, it will interact with the latex bead-labeled anti- NP antibodies on the conjugate pad. Required components 1. A foil pouch with a desiccant and a single use test card, 1 piece 3. Sterile swab, 1 piece 3. Extraction buffer tube (1 ml), 1 tube. 4. Instructions for use, 1 piece. Storage conditions 1. Store at the dark place, room temperature 18~28C with low humidity. 2. After opening the foil bag, please use the test cassette within 30 mins. 3. Expiration period 12 month Specimen requirements: 1. Nasopharyngeal swab specimen. 2.Specimen should be tested as soon as possible upon collection. If the sample has to be stored, store the swab sample at room temperature for up to 1 hour or 2~8C for up to 4 hours prior to testing. Performance Characteristics A total of 365 samples from suspected patients were tested by the RT-qPCR test. Testing results are shown in the following table: PCR AIVD Antigen Rapid Test Kit Positive Negative Positive 59 8 Negative 6 292 Total: 65 300 Sensitivity: 90.7%; Specificity: 97.3%.